Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 28 | 48 | 35 | 46 | 33 |
| Accounts receivable | -6 | -11 | 28 | -34 | 34 |
| Other Working Capital | 109 | 46 | 246 | 88 | -29 |
| Other Operating Activity | -1,503 | -1,689 | -1,378 | -2,219 | -2,396 |
| Operating Cash Flow | $-1,372 | $-1,605 | $-1,068 | $-2,119 | $-2,359 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -1 | -6 | -3 | -32 |
| Other Investing Activity | 0 | 135 | -302 | 51 | 3,777 |
| Investing Cash Flow | $0 | $134 | $-308 | $48 | $3,745 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -26 | -21 | N/A | N/A |
| Other Financing Activity | -65 | -30 | 0 | -25 | 0 |
| Financing Cash Flow | $-65 | $-55 | $-21 | $-25 | $0 |
| Exchange Rate Effect | 128 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 5,806 | 6,971 | 9,146 | 11,111 | 9,725 |
| End Cash Position | 4,497 | 5,793 | 6,971 | 9,146 | 11,111 |
| Net Cash Flow | $-1,436 | $-1,526 | $-1,397 | $-2,096 | $1,386 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,372 | -1,605 | -1,068 | -2,119 | -2,359 |
| Capital Expenditure | N/A | -1 | -6 | -3 | -32 |
| Free Cash Flow | -1,372 | -1,606 | -1,074 | -2,121 | -2,391 |